Recruiting A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers NCT05873686 Conditions Adenocarcinoma, Adenoma, Advanced Solid Tumor, +28 more Locations Mayo Clinic — Phoenix, Arizona, United States UC San Diego Moores Cancer Center — La Jolla, California, United States Sarah Cannon Research Institute at HealthONE — Denver, Colorado, United States Mayo Clinic — Jacksonville, Florida, United States View all 15 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression NCT06051695 Conditions Adenoma, Adnexal Diseases, Bronchial Neoplasms, +61 more Locations Banner Health — Gilbert, Arizona, United States UCSD Moores Cancer Center — La Jolla, California, United States UCLA Medical Center — Los Angeles, California, United States Stanford University — Stanford, California, United States View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression NCT05736731 Conditions Bronchial Neoplasms, CRC, Cancer, +38 more Locations Banner Health — Gilbert, Arizona, United States University of California San Diego — La Jolla, California, United States UCLA Medical Center — Los Angeles, California, United States Moffitt Cancer Center — Tampa, Florida, United States View more locations Show fewer locations Loading locations... View Trial Details
